Quantbot Technologies LP cut its position in Adient (NYSE:ADNT – Free Report) by 32.4% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 62,851 shares of the company’s stock after selling 30,131 shares during the quarter. Quantbot Technologies LP owned about 0.08% of Adient worth $1,513,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Hantz Financial Services Inc. lifted its stake in Adient by 62.6% in the third quarter. Hantz Financial Services Inc. now owns 1,140 shares of the company’s stock valued at $27,000 after acquiring an additional 439 shares during the last quarter. Raymond James Financial Inc. bought a new stake in shares of Adient in the 2nd quarter valued at about $63,000. Meeder Asset Management Inc. lifted its stake in Adient by 885.1% in the 3rd quarter. Meeder Asset Management Inc. now owns 7,093 shares of the company’s stock valued at $171,000 after purchasing an additional 6,373 shares during the last quarter. PNC Financial Services Group Inc. lifted its stake in Adient by 24.6% in the 3rd quarter. PNC Financial Services Group Inc. now owns 7,370 shares of the company’s stock valued at $177,000 after purchasing an additional 1,456 shares during the last quarter. Finally, iSAM Funds UK Ltd bought a new position in Adient during the second quarter worth about $213,000. 92.44% of the stock is owned by institutional investors.
Adient Stock Down 0.5%
ADNT stock opened at $22.05 on Friday. Adient has a fifty-two week low of $10.04 and a fifty-two week high of $27.32. The company has a debt-to-equity ratio of 1.17, a current ratio of 1.09 and a quick ratio of 0.88. The stock has a market capitalization of $1.73 billion, a price-to-earnings ratio of -6.09, a PEG ratio of 0.58 and a beta of 1.56. The business’s fifty day moving average price is $22.68 and its two-hundred day moving average price is $22.38.
Analyst Upgrades and Downgrades
A number of analysts have recently issued reports on the company. Stifel Nicolaus raised their price objective on Adient from $24.00 to $26.00 and gave the company a “buy” rating in a research report on Friday, January 23rd. Citigroup increased their price target on Adient from $22.50 to $30.00 and gave the company a “neutral” rating in a research note on Monday, February 9th. Barclays raised their price target on Adient from $25.00 to $27.00 and gave the company an “equal weight” rating in a report on Friday, February 6th. Bank of America started coverage on shares of Adient in a research report on Wednesday. They issued an “underperform” rating and a $22.00 price objective on the stock. Finally, JPMorgan Chase & Co. raised their target price on shares of Adient from $24.00 to $28.00 and gave the stock a “neutral” rating in a research note on Friday, February 6th. Four investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $27.67.
Get Our Latest Analysis on Adient
Adient Company Profile
Adient plc (NYSE: ADNT) is a leading global supplier of automotive seating and interior components. Established in 2016 through a spin-off from Johnson Controls, the company designs, engineers and manufactures complete seat assemblies, seat structures, mechanisms, foams, textiles, trim and electronics. Adient’s product portfolio spans a wide range of seating solutions, from entry-level designs to luxury and high-performance seats, and extends to interior modules such as door panels and center consoles.
Serving major original equipment manufacturers (OEMs) around the world, Adient works closely with automakers to develop lightweight, comfortable and safety-oriented seating systems.
Featured Stories
- Five stocks we like better than Adient
- Silver Is the New Oil—And the World’s Running Dry
- BNZI stands out as a Zacks Buy. Earnings momentum and analyst upgrades align
- What happened in Cyprus could be coming here
- Elon Musk’s $1 Quadrillion AI IPO
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Adient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adient and related companies with MarketBeat.com's FREE daily email newsletter.
